Status:
COMPLETED
Fenofibrate Versus Curcumin in Type 2 Diabetic Patients
Lead Sponsor:
Rehab Werida
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
35-70 years
Phase:
PHASE4
Brief Summary
The aim of this study is to evaluate the effect of fenofibrate versus curcumin on glycemic status, lipids profile, hs-CRP, sirtuin-1 and fetuin-A in type 2 diabetic patients who are taking glimepiride...
Detailed Description
Method \& Proposal Steps 1- Approval will be obtained from Research Ethics Committee of Faculty of Pharmacy, Damanhour University. 2- All participants agreed to take part in this clinical study and p...
Eligibility Criteria
Inclusion
- 60 Patients with type 2 DM diagnosed clinically.
- The age ranged from 35 to 70 years.
- There are no limits to the duration of DM and gender.
- HbA1c ≥ 7
Exclusion
- Other types of DM
- Hypersensitivity to the drug
- Abnormal liver function
- Patients with renal impairment (eGFR ≤ 60 ml/min)
- Addition of any antidiabetic medications or insulin during follows up.
- Pregnancy, lactation or child-bearing potential. 7. No insulin therapy and no use of antioxidants, multivitamin.
Key Trial Info
Start Date :
November 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04528212
Start Date
November 1 2020
End Date
December 1 2021
Last Update
March 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University Hospital
Tanta, El-Gharbia, Egypt, 31527